There is another perspective on the analysis of proposed CMS regulations as described in your article CMS plan could take a bite out of teleradiology night reads, published July 29.
The analysis of the regulations correctly states that motivated teleradiology companies will work hard to get their radiologists privileges at a hospital where it has contracted to provide extensive services. It also notes that hurdles to privileging might have the perverse effect of invoking resistance on the parts of hospitals when an incumbent radiology group seeks to obtain outsourced services.
But there is a problem with hospitals accepting the credentials of others (The Joint Commission, teleradiology companies, or other hospitals). That approach bypasses normal medical staff oversight. This is inimical to patient care and undermines the security of all medical staff: now radiologists-next, someone else.
At a time when there appears to be a reckless attitude on the part of shortsighted hospital CEOs and their boards of directors toward radiology service providers, many consultants and well-known radiologists are appropriately advising radiology practices to make medical staffs their allies. The benefits of these efforts are compounded because the medical staff has a strong role in credentialing.
Removing the local oversight of credentialing weakens what are potentially the only allies that patients and radiologists might have.
I submit that the benefits of medical staff involvement outweigh the potential disincentives to introducing teleradiology when a radiology practice seeks them out. In fact, the ACR has a policy that states, “The American College of Radiology regards care by onsite radiologists preferable to teleradiology, the latter being most useful as a supplement to onsite care for purposes such as subspecialty consultation and to provide coverage for underserved areas where the physical presence of a radiologist is not feasible.”
A decision to introduce outsourced providers to a hospital should be taken very seriously, and hurdles are appropriate.
Dr. Kaye chairs the radiology department at Bridgeport Hospital, Yale New Haven Health System, in Bridgeport, CT.
Comment: Hurdles to remote credentialing protect radiologists and quality of care
There is another perspective on the analysis of proposed CMS regulations as described in your article "CMS plan could take a bite out of teleradiology night reads," published July 29. There is a problem with hospitals accepting the credentials of others. That approach bypasses normal medical staff oversight. This is inimical to patient care and undermines the security of all medical staff: now radiologists-next, someone else.
There is another perspective on the analysis of proposed CMS regulations as described in your article CMS plan could take a bite out of teleradiology night reads, published July 29.
The analysis of the regulations correctly states that motivated teleradiology companies will work hard to get their radiologists privileges at a hospital where it has contracted to provide extensive services. It also notes that hurdles to privileging might have the perverse effect of invoking resistance on the parts of hospitals when an incumbent radiology group seeks to obtain outsourced services.
But there is a problem with hospitals accepting the credentials of others (The Joint Commission, teleradiology companies, or other hospitals). That approach bypasses normal medical staff oversight. This is inimical to patient care and undermines the security of all medical staff: now radiologists-next, someone else.
At a time when there appears to be a reckless attitude on the part of shortsighted hospital CEOs and their boards of directors toward radiology service providers, many consultants and well-known radiologists are appropriately advising radiology practices to make medical staffs their allies. The benefits of these efforts are compounded because the medical staff has a strong role in credentialing.
Removing the local oversight of credentialing weakens what are potentially the only allies that patients and radiologists might have.
I submit that the benefits of medical staff involvement outweigh the potential disincentives to introducing teleradiology when a radiology practice seeks them out. In fact, the ACR has a policy that states, “The American College of Radiology regards care by onsite radiologists preferable to teleradiology, the latter being most useful as a supplement to onsite care for purposes such as subspecialty consultation and to provide coverage for underserved areas where the physical presence of a radiologist is not feasible.”
A decision to introduce outsourced providers to a hospital should be taken very seriously, and hurdles are appropriate.
Dr. Kaye chairs the radiology department at Bridgeport Hospital, Yale New Haven Health System, in Bridgeport, CT.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 2
In a second part of a new podcast episode on recently published research on projected radiation-induced cancers from computed tomography (CT) scans, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., offer current perspectives on cardiac CT dosing, AI advances and the importance of teamwork in ensuring appropriate dosing for CT.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 1
In a new podcast, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., share their perspectives on recently published research looking at projections for future radiation-induced cancers from computed tomography (CT) scans.
SNMMI: Preliminary Research Suggests Dual-Targeting Radiopharmaceutical May Have Impact in Multiple Cancers
The dual-targeted 177Lu-DOTA-FAPI-RGD reportedly reduced or stopped the growth of cancer lesions in 88.9 percent of advanced adenocarcinomas in a small cohort of patients with varied cancers including pulmonary, pancreatic and ovarian cancer, according to new research presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 2
In a second part of a new podcast episode on recently published research on projected radiation-induced cancers from computed tomography (CT) scans, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., offer current perspectives on cardiac CT dosing, AI advances and the importance of teamwork in ensuring appropriate dosing for CT.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 1
In a new podcast, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., share their perspectives on recently published research looking at projections for future radiation-induced cancers from computed tomography (CT) scans.
SNMMI: Preliminary Research Suggests Dual-Targeting Radiopharmaceutical May Have Impact in Multiple Cancers
The dual-targeted 177Lu-DOTA-FAPI-RGD reportedly reduced or stopped the growth of cancer lesions in 88.9 percent of advanced adenocarcinomas in a small cohort of patients with varied cancers including pulmonary, pancreatic and ovarian cancer, according to new research presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.